These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 2858016

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Ifosfamide with mesna uroprotection in the management of lung cancer.
    Holoye PY, Glisson BS, Lee JS, Dhingra HM, Murphy WK, Umsawasdi T, Levy JK, Jeffries D, Raber MN, Hong WK.
    Am J Clin Oncol; 1990 Apr; 13(2):148-55. PubMed ID: 2156418
    [Abstract] [Full Text] [Related]

  • 27. Toxicity and response to high-dose ifosfamide + mesna as salvage therapy for advanced breast cancer.
    Steger GG, Dittrich C, Schlappack O, Mader R, Herold C, Brade WP, Keller A, Moser K.
    J Cancer Res Clin Oncol; 1988 Apr; 114(6):602-4. PubMed ID: 3144554
    [Abstract] [Full Text] [Related]

  • 28. Failure of 2-mercaptoethane sulphonate sodium (mesna) to protect against ifosfamide nephrotoxicity.
    Sangster G, Kaye SB, Calman KC, Dalton JF.
    Eur J Cancer Clin Oncol; 1984 Mar; 20(3):435-6. PubMed ID: 6423391
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Continuously improving ifosfamide/mesna: a winning combination.
    Anderson P.
    Pediatr Blood Cancer; 2010 Oct; 55(4):599-600. PubMed ID: 20589648
    [No Abstract] [Full Text] [Related]

  • 31. Early phase II Gynecologic Oncology Group experience with ifosfamide/mesna in gynecologic malignancies.
    Sutton GP, Blessing JA, Photopulos G, Berman ML, Homesley HD.
    Cancer Chemother Pharmacol; 1990 Oct; 26 Suppl():S55-8. PubMed ID: 2112054
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Interstitial pneumonitis associated with ifosfamide therapy.
    Baker WJ, Fistel SJ, Jones RV, Weiss RB.
    Cancer; 1990 May 15; 65(10):2217-21. PubMed ID: 2112039
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Encephalopathy in ifosfamide-treated patients.
    Merimsky O, Reider-Groswasser I, Wigler N, Chaitchik S.
    Acta Neurol Scand; 1992 Nov 15; 86(5):521-5. PubMed ID: 1481635
    [Abstract] [Full Text] [Related]

  • 36. Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma.
    Antman KH, Ryan L, Elias A, Sherman D, Grier HE.
    J Clin Oncol; 1989 Jan 15; 7(1):126-31. PubMed ID: 2491883
    [Abstract] [Full Text] [Related]

  • 37. Clinical studies of ifosfamide/mesna at St Jude Children's Research Hospital, 1983-1988.
    Pratt CB, Douglass EC, Etcubanas E, Goren MP, Green AA, Hayes FA, Horowitz ME, Meyer WH, Thompson EI, Wilimas JA.
    Semin Oncol; 1989 Feb 15; 16(1 Suppl 3):51-5. PubMed ID: 2495567
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Ifosfamide in the treatment of small cell carcinoma of the lung].
    Mukouda K, Morikawa E, Hasegawa K, Noumi K, Ohmura T, Mishima Y, Kawamoto M, Inagaki A, Kamitsuna A, Yamakido M, Nishimoto Y, Koyama T, Katsuta S.
    Gan To Kagaku Ryoho; 1983 May 15; 10(5):1293-8. PubMed ID: 6307164
    [Abstract] [Full Text] [Related]

  • 40. Mitomycin, ifosfamide, and mesna in the treatment of lung cancer.
    Dorr RT.
    Semin Oncol; 1990 Aug 15; 17(4 Suppl 7):2-5. PubMed ID: 2116668
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.